Q1 2025 Medexus Pharmaceuticals Inc Earnings Call Transcript
Greetings. Welcome to the Medexus first fiscal quarter 2025 earnings call. (Operator Instructions) Please note this conference is being recorded. I will now turn the call over to your host, Victoria Rutherford.
Ma'am, you may begin.
Thank you, and good morning, everyone. Welcome to the Medexus Pharmaceuticals first fiscal quarter 2025 earnings call. On the call this morning are Ken dâEntremont, Chief Executive Officer; and Brendan Buschman, Chief Financial Officer. If you have any questions after the conference call or would like further information about the company please contact Adelaide capital at 480-625-5772.
I would like to remind everyone that this discussion will include forward-looking information as defined in securities laws. Actual results may differ materially from historical results or results anticipated by the forward-looking information.
In addition, this discussion will also include non-GAAP measures, such as adjusted net income and loss and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |